Financials LiveCare, Inc.

Equities

LVCE

US53814W1045

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 10:07:30 25/04/2024 pm IST 5-day change 1st Jan Change
0.5888 USD -6.54% Intraday chart for LiveCare, Inc. -.--% +17.76%

Valuation

Fiscal Period: December 2021
Capitalization 1 70.9
Enterprise Value (EV) 1 69.19
P/E ratio -7.09 x
Yield -
Capitalization / Revenue 14,61,87,572 x
EV / Revenue 14,26,74,683 x
EV / EBITDA -94,24,711 x
EV / FCF 6,56,55,180 x
FCF Yield 0%
Price to Book 56.8 x
Nbr of stocks (in thousands) 32,226
Reference price 2 2.200
Announcement Date 21/06/22
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021
Net sales - - 0.485
EBITDA - -6.274 -7.342
EBIT 1 -0.7635 -6.275 -7.343
Operating Margin - - -1,514.17%
Earnings before Tax (EBT) 1 -0.7617 -7.337 -9.114
Net income 1 -0.7617 -7.337 -9.114
Net margin - - -1,879.28%
EPS 2 -0.0528 -0.3807 -0.3105
Free Cash Flow - 1.938 1.054
FCF margin - - 217.31%
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 30/04/21 30/04/21 21/06/22
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021
Net Debt 1 - 0.26 -
Net Cash position 1 0.24 - 1.7
Leverage (Debt/EBITDA) - -0.0417 x -
Free Cash Flow - 1.94 1.05
ROE (net income / shareholders' equity) - 4,367% -2,067%
ROA (Net income/ Total Assets) - -672% -268%
Assets 1 - 1.091 3.396
Book Value Per Share 2 0.0100 -0.0200 0.0400
Cash Flow per Share 2 0.0200 0.0400 0.0600
Capex - 0.01 0.04
Capex / Sales - - 8.14%
Announcement Date 30/04/21 30/04/21 21/06/22
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. LVCE Stock
  4. Financials LiveCare, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW